Enhancing Patient Recall in Urogynecologic Surgery

Sponsor
Atlantic Health System (Other)
Overall Status
Unknown status
CT.gov ID
NCT04010292
Collaborator
(none)
128
1
2
8.6
14.9

Study Details

Study Description

Brief Summary

Patient counseling is an essential part of any new treatment implementation. This process becomes even more important when it involves surgical counseling. This is when the patient and the surgeon discuss the possible surgical options and ideally establish a plan for the appropriate surgical intervention. Unfortunately, multiple studies have shown that patients tend to have poor recall of the key elements discussed during the consultation (1-3). In the investigators' experience, the concern lies specifically in the level of recall that patients have regarding their planned surgical procedure, as most patients cannot correctly state the planned intervention despite extensive counseling and explanation. Lack of knowledge about the type of surgery can have serious implications for the patient in the future. For example, knowing facts like the presence or absence of the cervix and whether future pap smears are needed or the presence of an implant, such as a mesh are necessary for the patient's well-being and proper medical care down the line, especially when the patient has multiple medical providers. In addition, previous research has demonstrated that low-quality counseling and the feeling of being "unprepared for surgery" directly correlate with patient dissatisfaction (4). This is especially relevant in the field of female pelvic reconstructive surgery, where the success of surgical interventions relies heavily upon subjective patient-reported outcomes (5).

There have been many studies to augment the counseling process using supplemental materials. These have included use of multiple visual charts, anatomical models, and passive and interactive audiovisual aids (6). Some improvement in the outcomes has been observed in various fields of medicine with the dissemination of supplemental patient resources (7-10). However, in urogynecology, the effectiveness of surgical counseling sessions has not been achieved despite the different additional methods for patient education (6, 11). Reasons that urogynecologic supplemental materials have not seen the same level of success as those in other fields of medicine include the complexity of the surgeries and the language used in many of these educational aids (12). The investigators aim to address the problem of poor patient recall of their procedure by providing them with an easy-to-read patient card detailing the anticipated surgery at the time of their consult.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Patient education card
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
128 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Enhancing Patient Recall in Urogynecologic Surgery
Actual Study Start Date :
Nov 14, 2019
Anticipated Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Aug 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patient education card

Behavioral: Patient education card
Patient who are randomized to receive a patient card at the end of the counseling visit will be able to take an index-card sized card with them which will highlight their anticipated surgery.

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Patient recall of the anticipated surgery during the preoperative visit [Patients will receive questionnaires within 30 days prior to their scheduled surgery.]

    All patient present for a preoperative visit, which occurs within 30 days of the scheduled surgery. At this time, all patients will receive a questionnaire testing their knowledge about their upcoming surgery. We will compare the answers from patients who received the education card and those who did not at the time of their surgical counseling visit. The name of the questionnaire is "The 7-Question Knowledge Questionnaire," which was developed by the Urogynecology Department at Atlantic Health System. The scale consists of 7 questions and will have score ranges between from 0 to 7.

Secondary Outcome Measures

  1. Patient recall of the surgery during the postoperative visit [Patients will receive questionnaires within 30 days of their surgery.]

    All patients will receive questionnaires, testing their knowledge of the performed surgery, during their postoperative follow-up visit. The questionnaire will include "The 7-Question Knowledge Questionnaire," which was developed by the Urogynecology Department at Atlantic Health System. The scale consists of 7 questions and will have score ranges between from 0 to 7.

  2. Patient satisfaction [Patients will receive questionnaires within 30 days of their surgery.]

    A validated questionnaire, called the "Leiden Perioperative care Patient Satisfaction questionnaire" will be given at the postoperative visit to determine patient satisfaction. A part of this questionnaire will be used, which consists of 4 questions. The total score will range between 0 and 4.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 89 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • English-speaking females, ages >18 and <90 years, present for surgical planning for reconstructive urogynecologic procedures
Exclusion Criteria:
  • Dementia, blindness, non-English speakers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Atlantic Urogynecology Associates Morristown New Jersey United States 07960

Sponsors and Collaborators

  • Atlantic Health System

Investigators

  • Principal Investigator: Charbel Salamon, MD, MS, Atlantic Health System

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
charbel salamon, PI/Medical Director of Urogynecology, Atlantic Health System
ClinicalTrials.gov Identifier:
NCT04010292
Other Study ID Numbers:
  • 1448021-1
First Posted:
Jul 8, 2019
Last Update Posted:
Feb 17, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2020